GITX Trademark

Trademark Overview

On Monday, April 20, 2020, a trademark application was filed for GITX with the United States Patent and Trademark Office. The USPTO has given the GITX trademark a serial number of 88879214. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 16, 2022. This trademark is owned by Genetic Intelligence, Inc.. The GITX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurodegeneration diseases, rare diseases, ocular diseases, lung diseases, and amyotrophic lateral sclerosis
gitx

General Information

Serial Number88879214
Word MarkGITX
Filing DateMonday, April 20, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 16, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 18, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurodegeneration diseases, rare diseases, ocular diseases, lung diseases, and amyotrophic lateral sclerosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 29, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenetic Intelligence, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10013
Party NameGenetic Intelligence, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10013

Trademark Events

Event DateEvent Description
Monday, May 16, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 16, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 7, 2021SOU EXTENSION 2 GRANTED
Thursday, October 7, 2021SOU EXTENSION 2 FILED
Thursday, October 7, 2021TEAS EXTENSION RECEIVED
Friday, April 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 7, 2021SOU EXTENSION 1 GRANTED
Wednesday, April 7, 2021SOU EXTENSION 1 FILED
Wednesday, April 7, 2021TEAS EXTENSION RECEIVED
Tuesday, April 6, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 6, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, April 6, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 6, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 13, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 18, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 18, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 13, 2020ASSIGNED TO EXAMINER
Wednesday, April 29, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 24, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 24, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 24, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 23, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

gitx diseases lung amyotrophic lateral sclerosis ocular rare preparations treatment neurodegeneration